Rosiñol L - Search Results

1

Prognostic impact of immunoparesis at diagnosis and after treatment onset in patients with light-chain amyloidosis.

Rodríguez-Lobato LG, Fernández de Larrea C, Cibeira MT, Tovar N, Isola I, Aróstegui JI, Rosiñol L, Díaz T, Lozano E, Yagüe J, Bladé J. Rodríguez-Lobato LG, et al. Among authors: rosinol l. Amyloid. 2017 Dec;24(4):245-252. doi: 10.1080/13506129.2017.1390451. Epub 2017 Oct 20. Amyloid. 2017. PMID: 29052436 Clinical Trial.

2

Thalidomide in refractory and relapsing multiple myeloma.

Bladé J, Esteve J, Rosiñol L, Perales M, Montoto S, Tuset M, Montserrat E. Bladé J, et al. Among authors: rosinol l. Semin Oncol. 2001 Dec;28(6):588-92. Semin Oncol. 2001. PMID: 11740814

3

Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance.

Bladé J, Filella X, Montoto S, Bosch F, Rosiñol L, Coca F, Giné E, Nadal E, Aymerich M, Rozman M, Montserrat E. Bladé J, et al. Among authors: rosinol l. Br J Haematol. 2002 May;117(2):387-9. doi: 10.1046/j.1365-2141.2002.03424.x. Br J Haematol. 2002. PMID: 11972522 Free article.

4

Primary systemic amyloidosis presenting as a colonic stricture: successful treatment with left hemicolectomy followed by autologous hematopoietic stem-cell transplantation: report of a case.

Rives S, Pera M, Rosiñol L, Vidal O, Miquel R, Solé M, García-Valdecasas J, Bladé J. Rives S, et al. Among authors: rosinol l. Dis Colon Rectum. 2002 Sep;45(9):1263-6. doi: 10.1007/s10350-004-6403-x. Dis Colon Rectum. 2002. PMID: 12352247

5

Thalidomide: a step forward in the treatment of malignant monoclonal gammopathies.

Bladé J, Rosiñol L. Bladé J, et al. Among authors: rosinol l. Clin Lymphoma. 2003 Mar;3(4):247-8. doi: 10.1016/s1526-9655(11)70186-5. Clin Lymphoma. 2003. PMID: 12672275 No abstract available.

6

Malignant transformation in IgM monoclonal gammopathy of undetermined significance.

Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E. Montoto S, et al. Among authors: rosinol l. Semin Oncol. 2003 Apr;30(2):178-81. doi: 10.1053/sonc.2003.50067. Semin Oncol. 2003. PMID: 12720132

7

Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?

Bladé J, Montoto S, Rosiñol L, Montserrat E. Bladé J, et al. Among authors: rosinol l. Semin Oncol. 2003 Apr;30(2):329-31. doi: 10.1053/sonc.2003.50055. Semin Oncol. 2003. PMID: 12720163

8

Smoldering multiple myeloma: natural history and recognition of an evolving type.

Rosiñol L, Bladé J, Esteve J, Aymerich M, Rozman M, Montoto S, Giné E, Nadal E, Filella X, Queralt R, Carrió A, Montserrat E. Rosiñol L, et al. Br J Haematol. 2003 Nov;123(4):631-6. doi: 10.1046/j.1365-2141.2003.04654.x. Br J Haematol. 2003. PMID: 14616966 Free article.

9

High-dose therapy/autologous stem cell transplantation in patients with chemosensitive multiple myeloma: predictors of complete remission.

Nadal E, Giné E, Bladé J, Esteve J, Rosiñol L, Fernández-Avilés F, Marin P, Martinez C, Rovira M, Urbano-Ispizua A, Carreras E, Montserrat E. Nadal E, et al. Among authors: rosinol l. Bone Marrow Transplant. 2004 Jan;33(1):61-4. doi: 10.1038/sj.bmt.1704313. Bone Marrow Transplant. 2004. PMID: 14704657 Clinical Trial.

10

Moving forward in myeloma research.

Bladé J, Rosiñol L. Bladé J, et al. Among authors: rosinol l. Haematologica. 2004 May;89(5):517-9. Haematologica. 2004. PMID: 15136212 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

274 results

Search Page

Filters